Literature DB >> 2315873

Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices.

C O'Callaghan1.   

Abstract

An impactor method was used to assess the amount of beclomethasone dipropionate in particles less than 5 microns produced by two nebulisers (Pari Inhalierboy, Medix Traveller compressor with cirrhus nebuliser chamber) and two spacer devices (Volumatic and Nebuhaler). After nebulisation of 3 ml (150 micrograms) beclomethasone dipropionate the amount of drug in particles less than 5 microns was 16 micrograms (GSD 1.1) with the Pari Inhalierboy, and 27 micrograms (1.4) with the Medix Traveller with cirrhus nebuliser. This was less than the amount in particles less than 5 microns after three metered dose inhaler actuations (150 micrograms) from the Nebuhaler (58.2 (1) micrograms) or the Volumatic spacer (46.5 (1) micrograms). The greater amount of beclomethasone dipropionate in small particles with administration from a metered dose inhaler with a spacer device means that considerably more drug is likely to reach the airways than when the same dose is given by the two nebulisers studied.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315873      PMCID: PMC462319          DOI: 10.1136/thx.45.2.109

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  Spacer device with face mask attachment for giving bronchodilators to infants with asthma.

Authors:  C O'Callaghan; A D Milner; A Swarbrick
Journal:  BMJ       Date:  1989-01-21

2.  Artificial urinary sphincters.

Authors:  A R Mundy
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

3.  Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis.

Authors:  K H Carlsen; J Leegaard; S Larsen; I Orstavik
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

4.  Why nebulise for more than five minutes?

Authors:  C O'Callaghan; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

5.  The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate.

Authors:  C Maayan; T Itzhaki; E Bar-Yishay; S Gross; A Tal; S Godfrey
Journal:  Pediatr Pulmonol       Date:  1986 Jan-Feb

6.  Nebulised beclomethasone dipropionate in preschool asthma.

Authors:  J Storr; C A Lenney; W Lenney
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

  6 in total
  13 in total

1.  Inhaled budesonide for chronic wheezing under 18 months of age.

Authors:  V Noble; N R Ruggins; M L Everard; A D Milner
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

2.  Delivering inhaled corticosteroids to patients.

Authors:  C O'Callaghan; P Barry
Journal:  BMJ       Date:  1999-02-13

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 4.  Nebuliser therapy in childhood.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 5.  The science of nebulised drug delivery.

Authors:  C O'Callaghan; P W Barry
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

6.  How to get drugs into the respiratory tract.

Authors:  C O'Callaghan
Journal:  Arch Dis Child       Date:  1993-04       Impact factor: 3.791

7.  Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing.

Authors:  G F Fox; M L Everard; M J Marsh; A D Milner
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 8.  Once-daily inhaled corticosteroids in children with asthma: nebulisation.

Authors:  G Shapiro
Journal:  Drugs       Date:  1999       Impact factor: 9.546

9.  Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension.

Authors:  P Ilangovan; S Pedersen; S Godfrey; K Nikander; N Noviski; J O Warner
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

10.  Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?

Authors:  C O'Callaghan; M Cant; C Robertson
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.